Related Experiment Video
Updated: Feb 10, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Pulmonary Embolism in Children
Sarah Ramiz1, Madhvi Rajpurkar1
1Division of Pediatric Hematology Oncology, Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Children's Hospital of Michigan, 3901 Beaubien Street, Detroit, MI 48201, USA.
Insights
Pulmonary embolism (PE) in children is a rare but serious condition with increasing incidence. Current management is based on adult data, highlighting the need for pediatric-specific guidelines.
Area of Science:
- Pediatric Medicine
- Cardiovascular Research
- Hematology
Background:
- Pulmonary embolism (PE) in children is uncommon but carries significant mortality risk.
- PE incidence is rising due to improved survival in high-risk children, increased central venous catheter use, and better recognition.
- Current pediatric PE management relies on adult guidelines, despite distinct differences in the condition.
Purpose of the Study:
- To review the current understanding of pediatric pulmonary embolism.
- To highlight the need for evidence-based, pediatric-specific diagnostic and management guidelines.
- To discuss current and future treatment strategies, including anticoagulation.
Main Methods:
- Review of existing literature on pediatric pulmonary embolism.
- Analysis of factors contributing to increased PE incidence in children.
- Examination of current treatment modalities and ongoing research.
Main Results:
- Pediatric PE, while rare, is increasingly diagnosed.
- Management strategies are largely extrapolated from adult protocols.
- Direct oral anticoagulants are under investigation for pediatric use.
Conclusions:
- There is a critical need for pediatric-specific research to establish evidence-based guidelines for PE diagnosis and management.
- Optimizing treatment requires a better understanding of the unique aspects of PE in children.
- Further investigation into novel anticoagulants is warranted for this population.
Abstract:
Pulmonary embolism (PE) in children is a rare condition with potential for high mortality. PE incidence is increasing owing to increased survival of children with predisposing conditions, increased use of central venous catheters, and improved awareness and recognition. Although pediatric PE is distinct from adult PE, management guidelines in children are extrapolated from the adult data. Treatment includes thrombolysis or thrombectomy, and pharmacologic anticoagulation. Ongoing clinical trials are evaluating the use of direct oral anticoagulants in children. Further research is required to develop pediatric-specific evidence-based guidelines for diagnosis and management of PE.
Related Concept Videos
Pulmonary Embolism I: Introduction
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Drug Dosing: Infants and Children
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

